ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

ACS-Roosevelt Awards Announced

June 22, 1979

Digital Immunoassay PSA Test May Predict Cancer Recurrence

October 28, 2011

PHS Revises Lab Animal Policies

May 10, 1985

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Donald Coffey Is President-Elect Of NCCR; Coalition Elects Five New Board.

January 28, 2000

ACS announces 415 New Awards

August 31, 1979